- Can AI predict clinical trial outcomes?
by aaavl2821 on 6/12/25, 7:14 PM, with comments
- AI won't replace biotech analysts
by aaavl2821 on 6/11/25, 11:07 PM, with comments
- Show HN: Research Pharma Markets with AI
by aaavl2821 on 3/27/25, 8:02 PM, with comments
- Show HN: Search for drugs approved to treat a given disease
by aaavl2821 on 1/30/25, 5:42 PM, with comments
- Better obesity drugs are coming soon
by aaavl2821 on 10/8/24, 4:37 PM, with comments
- The Future of the Obesity Market
by aaavl2821 on 10/3/24, 5:07 PM, with comments
- The obesity drug landscape in one chart
by aaavl2821 on 8/15/24, 6:21 PM, with comments
- A primer on the obesity drug landscape
by aaavl2821 on 8/13/24, 7:20 PM, with comments
- AI-enabled biotech startup analysis
by aaavl2821 on 10/30/23, 6:30 PM, with comments
- Analyzing gene therapy startup in layman's terms
by aaavl2821 on 10/27/23, 3:20 AM, with comments
- AI Analysis of Biotech Startups
by aaavl2821 on 10/20/23, 8:48 PM, with comments
- AI investment analyst: initiating coverage on Neumora Therapeutics
by aaavl2821 on 10/5/23, 6:22 PM, with comments
- Quantifying risk / reward in biotech investing
by aaavl2821 on 9/27/23, 5:30 PM, with comments
- Valuing Biotech Licensing Deals
by aaavl2821 on 7/10/23, 5:50 PM, with comments
- Show HN: Value Biotech Licensing Deals
by aaavl2821 on 7/6/23, 6:16 PM, with comments
- Which VCs are still investing in biopharma?
by aaavl2821 on 5/4/23, 9:30 PM, with comments
- Biotech VC on pace for worst year since 2016
by aaavl2821 on 5/4/23, 8:48 PM, with comments
- The biotech venture capital crunch
by aaavl2821 on 4/12/23, 6:50 PM, with comments
- Show HN: Interactive guide to valuing biotech companies
by aaavl2821 on 3/22/23, 9:49 PM, with comments
- Diagnosing the problem with biotech R&D
by aaavl2821 on 9/21/22, 4:21 PM, with comments
- Is Biotech Investing Sustainable?
by aaavl2821 on 9/8/22, 7:40 PM, with comments
- The next generation of biotech VCs
by aaavl2821 on 8/11/22, 9:17 PM, with comments
- Will a Recession Save Biotech?
by aaavl2821 on 7/21/22, 7:04 PM, with comments
- Biotech platforms are out, products are back in
by aaavl2821 on 6/20/22, 11:25 PM, with comments
- Bargain hunting for biotech stocks [video]
by aaavl2821 on 6/18/22, 1:35 AM, with comments
- Can big pharma buy every biotech startup?
by aaavl2821 on 6/10/22, 8:37 PM, with comments
- Biotech crossover investors facing steep losses
by aaavl2821 on 6/7/22, 8:55 PM, with comments
- Who is still investing in biotech startups?
by aaavl2821 on 5/24/22, 7:09 PM, with comments
- Biotech's New Normal
by aaavl2821 on 5/12/22, 6:28 PM, with comments
- The Biotech M&a Gap
by aaavl2821 on 5/5/22, 8:56 PM, with comments
- Who Will Save Biotech?
by aaavl2821 on 5/2/22, 5:32 PM, with comments
- Biotech VC funding down 60% in March
by aaavl2821 on 4/12/22, 7:15 PM, with comments
- Biotech investors are slashing exposure to IPOs
by aaavl2821 on 3/17/22, 9:50 PM, with comments
- Big investors slashing exposure to early-stage biotech stocks
by aaavl2821 on 3/10/22, 9:59 PM, with comments
- Biotech from Bust to Boom
by aaavl2821 on 3/8/22, 5:31 PM, with comments
- Biotech from Bust to Boom
by aaavl2821 on 3/3/22, 7:53 PM, with comments
- Case study in analyzing clinical trial risk [video]
by aaavl2821 on 2/23/22, 6:08 PM, with comments
- A framework for analyzing biotech clinical trial risk [video]
by aaavl2821 on 2/16/22, 9:20 PM, with comments
- The Biotech IPO Crunch
by aaavl2821 on 1/24/22, 10:22 PM, with comments
- Was FDA's review of aducanumab biased? [video]
by aaavl2821 on 1/19/22, 6:58 PM, with comments
- Valuations of biotech startups from Series A to IPO
by aaavl2821 on 1/18/22, 1:06 AM, with comments
- Analyzing clinical data of a controversial Alzheimer's drug [video]
by aaavl2821 on 11/9/21, 11:46 PM, with comments
- Intro to interpreting clinical data for biotech investing [video]
by aaavl2821 on 11/1/21, 11:14 PM, with comments
- Intro to Biotech DCF Analysis [video]
by aaavl2821 on 10/20/21, 8:13 PM, with comments
- Intro to Valuation in Biotech [video]
by aaavl2821 on 10/13/21, 6:31 PM, with comments
- The VC power law: biotech vs. tech
by aaavl2821 on 9/9/21, 10:13 PM, with comments
- Biotech investing basics: measuring value
by aaavl2821 on 9/3/21, 3:23 AM, with comments
- The VC power law: tech vs. biotech
by aaavl2821 on 9/2/21, 2:24 AM, with comments
- Biotech investing basics: value creation in biotech [video]
by aaavl2821 on 8/25/21, 12:37 AM, with comments